Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.
Letter from the Chairs
It is our pleasure to invite you to join us for Lymphoma & Myeloma 2012: An International Congress on Hematologic Malignancies. This fall’s Congress, October 25-27, 2012, will once again be held at the beautiful and historic Waldorf=Astoria in New York, New York.
Since its inception in 2000, this Congress has grown to nearly 1,000 attendees from over 40 countries, becoming the premier forum on the latest advances in lymphoma, myeloma and related disorders. This dynamic three-day educational event will include numerous opportunities for lively interaction via audience polling on challenging clinical scenarios, expert-guided discussions, and exciting debates on current clinical controversies. Attendees from all relevant medical specialties will be able to benefit from case-based discussions and didactic lectures incorporating aspects of molecular biology, pathology, immunology and translational and clinical research. Attendees can expect to leave this conference with not only a greater understanding of how to use novel agents safely and with improved patient outcomes but also a thorough understanding of how hypothesis-driven translational and clinical research has lead to the development of these promising agents and novel therapeutic combinations.
Attendees of the Lymphoma & Myeloma 2012 Congress will have the added benefit of visiting the cultural melting pot that is New York City during one of the most beautiful times of year. This Congress will be the perfect chance for you to get away and enjoy a weekend of educational activities in the capital city of the world!
Please join us in New York for what promising to be an exciting, informative, and rewarding educational experience!
Morton Coleman, MD, Chair
John P. Leonard, MD, Co-Chair, Lymphoma Session
Ruben Niesvizky, MD, Co-Chair, Myeloma Session
Richard R. Furman, MD, Co-Chair, Leukemia Session
The following associations have endorsed this congress:
The International Waldenstrom’s Macroglobulinemia Foundation (IWMF) was established in 1994 to serve the community of patients with Waldenstrom’s macroglobulinemia (WM), a rare B-cell lymphoma. It is operated by a volunteer Board of Trustees, with Dr. Robert A. Kyle of the Mayo Clinic serving as a Trustee, Board advisor, and Chair of the Foundation’s Scientific Advisory Committee.
The IWMF is dedicated to offering support and encouragement to those affected by Waldenstrom’s macroglobulinemia, to provide information and educational programs that address patients’ concerns, and to promote and support research leading to improved treatments and an ultimate cure for the disease.
The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.
LLS is the world's largest voluntary health agency dedicated to blood cancer. LLS funds lifesaving blood cancer research around the world and provides free information and support services.
LLS provides educational, emotional, and financial support to patients and families touched by blood cancers. We provide education and resources for healthcare professionals, and advocate for public policies that affect our cancer community. For additional information, please visit lls.org
The Lymphoma Research Foundation(LRF) is the nation's largest non-profit organization devoted exclusively to funding innovative lymphoma research and providing people with lymphoma and healthcare professionals with up-to-date information about this type of cancer. LRF's mission is to eradicate lymphoma and serve those touched by this disease. LRF’s goal is to change the future for everyone whose life has been affected by a lymphoma diagnosis. LRF is dedicated to funding biomedical research focused on the origins, treatment and identification of a cure for lymphoma; to raising public awareness of the disease; and providing support and services to people with lymphoma, their families and caregivers.
The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)(3) non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's diagnosis with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. As the world's number-one private funder of multiple myeloma research, the MMRF has raised over $200 million since its inception and directs 90% of total budget to research and related programming. As a result, the MMRF has been awarded Charity Navigator’s coveted four star rating for nine consecutive years, the highest designation for outstanding fiscal responsibility and exceptional efficiency. For more information about the MMRF, please visit www.themmrf.org.
The New York Cancer Society
The New York Cancer Society is a not-for-profit organization that was formed in the early 1950s, with the support of the American Cancer Society, to support the multi-disciplinary exchange of clinical information. The society currently has a membership of over 300 members including medical oncologists, radiation oncologists and surgical oncologists. Each academic year we host four educational symposiums either addressing updates in new cancer therapies or regulatory issues that directly impact the delivery of cancer services. Every major academic center in the tri-state area is represented.
NewYork-Presbyterian Hospital is one of the foremost academic medical centers in the world, with leading specialists in every field of medicine and a staff dedicated to the care of its patients.
NewYork-Presbyterian enjoys a unique affiliation with two of the nation’s leading Ivy League medical schools: Columbia University College of Physicians and Surgeons and Weill Cornell Medical College. With its academic partners, the Hospital shares a commitment to pursuing clinical excellence, engaging in groundbreaking biomedical research, offering outstanding medical education, and providing prevention and wellness services to the community.
Imedex is Going Green!
In a continuing effort to be environmentally conscious Imedex will be offering speaker presentations online one week before the meeting begins. You can either download these presentations to your laptop or other electronic device or print them out and bring them onsite with you. A link to download the presentations will be emailed to you. Printed versions of the presentations will not be available onsite.
For registration inquiries:
Tel.: +1 (678) 242-0906
Toll-free (USA only): +1 (800) 233-0957
Fax: +1 (770) 751-7334